Means Investment Company’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-22,950
| Closed | -$660K | – | 192 |
|
|
2024
Q1 | $660K | Sell |
22,950
-8,220
| -26% | -$236K | 0.09% | 113 |
|
|
2023
Q4 | $1.02M | Sell |
31,170
-6,714
| -18% | -$220K | 0.15% | 92 |
|
|
2023
Q3 | $1.06M | Sell |
37,884
-3,584
| -9% | -$99.8K | 0.17% | 91 |
|
|
2023
Q2 | $1.41M | Sell |
41,468
-1,780
| -4% | -$60.7K | 0.22% | 82 |
|
|
2023
Q1 | $1.3M | Sell |
43,248
-932
| -2% | -$28K | 0.23% | 83 |
|
|
2022
Q4 | $1.25M | Sell |
44,180
-32,146
| -42% | -$907K | 0.25% | 81 |
|
|
2022
Q3 | $2.51M | Buy |
76,326
+484
| +0.6% | +$15.9K | 0.54% | 40 |
|
|
2022
Q2 | $2.39M | Buy |
75,842
+314
| +0.4% | +$9.89K | 0.51% | 43 |
|
|
2022
Q1 | $3.47M | Buy |
75,528
+753
| +1% | +$34.6K | 0.63% | 32 |
|
|
2021
Q4 | $4.58M | Buy |
74,775
+5,246
| +8% | +$321K | 0.81% | 22 |
|
|
2021
Q3 | $5.2M | Buy |
69,529
+4,786
| +7% | +$358K | 1.03% | 19 |
|
|
2021
Q2 | $5.99M | Buy |
64,743
+5,642
| +10% | +$522K | 1.2% | 19 |
|
|
2021
Q1 | $5.24M | Buy |
59,101
+2,286
| +4% | +$203K | 1.19% | 19 |
|
|
2020
Q4 | $6.3M | Buy |
56,815
+13,728
| +32% | +$1.52M | 1.44% | 14 |
|
|
2020
Q3 | $3.14M | Buy |
43,087
+19,718
| +84% | +$1.44M | 0.86% | 23 |
|
|
2020
Q2 | $1.32M | Buy |
+23,369
| New | +$1.32M | 0.41% | 53 |
|